Overview
Healthcare-at-home provider's Q4 revenue beat analyst expectations
Q4 operating loss and pretax loss wider than analyst expectations
Company expanded footprint by acquiring HME provider in Hawaii
Outlook
AdaptHealth forecasts 2026 net revenue between $3.44 bln and $3.51 bln
Company expects 2026 adjusted EBITDA of $680 mln to $730 mln
AdaptHealth projects 2026 free cash flow of $175 mln to $225 mln
Result Drivers
PATIENT GROWTH - AdaptHealth set new patient census records in Sleep Health, Respiratory Health, and Wellness at Home
GEOGRAPHIC EXPANSION - Acquired a leading HME provider in Hawaii, expanding the company's footprint to its 48th state
DIGITAL ENGAGEMENT - More than doubled myApp users to 327,300, enhancing digital patient engagement
Company press release: ID:nBw8nk0Wma
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Beat | $846.29 mln | $831.61 mln (8 Analysts) |
Q4 Net Income | -$101.54 mln | ||
Q4 Operating Income | Miss | -$73.28 mln | $89.60 mln (8 Analysts) |
Q4 Pretax Profit | Miss | -$97.99 mln | $65.06 mln (7 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Adapthealth Corp is $13.00, about 26.3% above its February 23 closing price of $10.29
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 8 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)